FBLG
Income statement / Annual
Last year (2023), FibroBiologics, Inc. Common Stock's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, FibroBiologics, Inc. Common Stock's net income was -$16.49 M.
See FibroBiologics, Inc. Common Stock’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$437,000.00 |
$94,000.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$437,000.00 |
-$94,000.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$2.37 M
|
$1.15 M
|
$521,000.00
|
$669,000.00
|
| General & Administrative
Expenses |
$5.84 M
|
$3.32 M
|
$1.06 M
|
$500,000.00
|
| Selling & Marketing
Expenses |
$685,000.00
|
-$94,000.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$6.52 M
|
$3.23 M
|
$1.06 M
|
$500,000.00
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$8.89 M |
$4.37 M |
$1.58 M |
$1.17 M |
| Cost And Expenses |
$8.89 M |
$4.47 M |
$1.58 M |
$1.17 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$147,000.00 |
$654,000.00 |
$4,000.00 |
$0.00 |
| Depreciation &
Amortization |
$437,000.00
|
$94,000.00
|
$0.00
|
$1.17 M
|
| EBITDA |
-$15.90 M
|
-$4.37 M
|
-$1.58 M
|
$0.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$7.60 M
|
-$654,000.00
|
-$4,000.00
|
$0.00
|
| Income Before Tax |
-$16.49 M |
-$5.12 M |
-$1.58 M |
-$1.17 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Net Income |
-$16.49 M |
-$5.12 M |
-$1.58 M |
-$1.17 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
| EPS |
-0.59 |
-0.16 |
-0.0487 |
-0.13 |
| EPS Diluted |
-0.68 |
-0.16 |
-0.0487 |
-0.13 |
| Weighted Average Shares
Out |
$32.49 M
|
$32.49 M
|
$32.49 M
|
$8.75 M
|
| Weighted Average Shares
Out Diluted |
$28.23 M
|
$32.49 M
|
$32.49 M
|
$8.75 M
|
| Link |
|
|
|
|
